FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * DEMANE MICHAEL F   2. Issuer Name and Ticker or Trading Symbol NEVRO CORP [NVRO] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chief Executive Officer (Last) (First) (Middle) C/O NEVRO CORP., 1800 BRIDGE PARKWAY 3. Date of Earliest Transaction (Month/Day/Year) 03/01/2016 (Street) REDWOOD CITY, CA 94065 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 03/01/2016   S(1)   16,314 D $ 55.0962 (2) 562,940 (3) D   Common Stock 03/01/2016   S(1)   8,688 D $ 56.8019 (4) 554,252 D   Common Stock 03/01/2016   S(1)   1,465 D $ 57.7985 (5) 552,787 D   Common Stock 03/01/2016   S(1)   200 D $ 59.0625 (6) 552,587 D   Common Stock 03/01/2016   S(1)   6,058 D $ 55.0084 (7) 99,828 (3) I See foonote (8) Common Stock 03/01/2016   S(1)   150 D $ 56.2233 (9) 99,678 I See foonote (8) Common Stock 03/01/2016   S(1)   408 D $ 57.7462 (10) 99,270 I See foonote (8) Common Stock 03/01/2016   S(1)   50 D $ 58.99 99,220 I See foonote (8) Common Stock 03/01/2016   S(1)   6,059 D $ 55.0084 (11) 31,528 I See foonote (12) Common Stock 03/01/2016   S(1)   150 D $ 56.2233 (13) 31,378 I See foonote (12) Common Stock 03/01/2016   S(1)   407 D $ 57.7463 (14) 30,971 I See foonote (12) Common Stock 03/01/2016   S(1)   50 D $ 58.99 30,921 I See foonote (12)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
DEMANE MICHAEL F C/O NEVRO CORP. 1800 BRIDGE PARKWAY REDWOOD CITY, CA 94065	X		Chief Executive Officer

Signatures

/s/ Andrew Galligan, as Attorney-in-Fact for Michael DeMane		03/03/2016
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
(2)	The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.69, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
(3)	Includes 5,313 shares previously held by The Michael F. DeMane 2012 Retained Annuity Trust u/a/d July 26, 2012 which were distributed to the Reporting Person on November 19, 2015 and are now owned directly.
(4)	The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $56.13 to $57.02, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
(5)	The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $57.72 to $58.0154, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
(6)	The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $59.05 to $59.075, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
(7)	The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.15, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
(8)	Shares held by Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012 (the "Irrevocable Trust"). 105,886 shares previously held by The Michael F. DeMane 2012 Retained Annuity Trust u/a/d July 26, 2012 were transferred to the Irrevocable Trust on February 23, 2016.
(9)	The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $56.14 to $56.29, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
(10)	The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $57.5852 to $57.85, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
(11)	The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.15, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
(12)	Shares held by The Michael F. DeMane 2013 Retained Annuity Trust.
(13)	The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $56.14 to $56.29, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
(14)	The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $57.5852 to $57.85, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.